Skip to Content

Facts and Figures in R&D

Chart of R&D expenditures

Roche spends more than 8 billion Swiss francs on research and development and employs over 7000 people in R&D.

A unique R&D network model and strong alliances with companies, universities and research institutions worldwide give our scientists broadest access to innovation.

Group R&D Expenditures in millions of CHF
20082007% change
CHF
% change
LC
2008
% of sales
2007
% of sales
Group8,8458,385+ 5+ 1319.418.2
Divisional R&D Expenditures in millions of CHF
2008% change
CHF
% change
LC
% of sales
Pharmaceuticals7,90441122.0
Diagnostics94120269.7

Roche has Pharma Research centers around the world with more than 2500 scientists passionate about discovering medicines to meet the unmet medical needs of patients.

In Pharma Development about 4,000 scientists and physicians around the world design and conduct preclinical and clinical trials to transform promising compounds into clinically differentiated medicines for patients.

The Research and Development sites focus on specific Disease Biology Areas or on strategic areas of research technologies and/or specific areas in preclinical or clinical development.  They are:

LocationFocus area
Basel, Switzerland (R&D)Metabolics and Central Nervous System
Kulmbach Germany (R)RNA-based Therapeutics
Madison (WI), USA (R)RNA interference
Nutley (NJ), USA (R&D)Oncology and Metabolics
Palo Alto (CA), USA (R)Inflammation and Virology
Penzberg, Germany (R)Protein Therapeutics
Schlieren, Switzerland (R)Antibody engineering
Shanghai, China (R&D)Research and Clinical Development
Sydney, Australia (D)Clinical Development Operations
Toronto, Canada (R)Antibody Therapeutics
Welwyn, United Kingdom (D)Pharmaceutical Development